Audit 366208

FY End
2024-12-31
Total Expended
$98.98M
Findings
0
Programs
42
Organization: Intermountain Health Care Inc. (UT)
Year: 2024 Accepted: 2025-09-12
Auditor: Kpmg

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
97.036 (covid-19) Disaster Grants - Public Assistance $67.96M - 0
21.029 Coronavirus Capital Projects Fund $18.00M Yes 0
93.516 Public Health Training Centers Program $634,437 - 0
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $405,325 - 0
93.350 National Center for Advancing Translational Sciences $388,693 - 0
93.859 Biomedical Research and Research Training $382,879 - 0
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $326,013 Yes 0
93.045 Special Programs for the Aging, Title Iii, Part C, Nutrition Services $290,899 - 0
93.211 Telehealth Programs $262,689 - 0
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $192,317 - 0
93.068 Chronic Diseases: Research, Control, and Prevention $168,167 - 0
94.011 Americorps Seniors Foster Grandparent Program $133,451 - 0
93.052 National Family Caregiver Support, Title Iii, Part E $108,029 - 0
93.257 Grants for Education, Prevention, and Early Detection of Radiogenic Cancers and Diseases $84,670 - 0
93.110 Maternal and Child Health Federal Consolidated Programs $80,921 - 0
93.865 Child Health and Human Development Extramural Research $69,789 - 0
93.301 Small Rural Hospital Improvement Grant Program $58,907 - 0
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $53,725 - 0
93.837 Cardiovascular Diseases Research $49,246 - 0
12.420 Military Medical Research and Development $48,595 - 0
93.839 Blood Diseases and Resources Research $47,976 - 0
93.127 Emergency Medical Services for Children $43,525 - 0
93.365 Sickle Cell Treatment Demonstration Program $40,438 - 0
93.866 Aging Research $37,823 - 0
93.084 Prevention of Disease, Disability, and Death by Infectious Diseases $32,718 - 0
93.399 Cancer Control $32,229 - 0
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $24,742 - 0
93.889 National Bioterrorism Hospital Preparedness Program $23,075 - 0
93.242 Mental Health Research Grants $22,290 - 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $20,192 - 0
93.395 Cancer Treatment Research $18,394 - 0
20.616 National Priority Safety Programs $15,309 - 0
93.172 Human Genome Research $14,615 - 0
21.027 Coronavirus State and Local Fiscal Recovery Funds $10,385 - 0
93.393 Cancer Cause and Prevention Research $8,674 - 0
93.917 Hiv Care Formula Grants $7,480 - 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $7,343 - 0
93.044 Special Programs for the Aging_title Iii, Part B, Grants for Supportive Services and Senior Centers $4,604 - 0
93.838 Lung Diseases Research $1,823 - 0
93.226 Research on Healthcare Costs, Quality and Outcomes $160 - 0
93.855 Allergy and Infectious Deseases Research $160 - 0
93.261 Scaling the National Diabetes Prevention Program to Priority Populations $-882 - 0

Contacts

Name Title Type
HVWJJCAW86H3 Carlee Dickson Auditee
8014423776 Jennie Lindstrom Auditor
No contacts on file

Notes to SEFA

Title: 1. Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in 45 CFR 74, Appendix E or the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The Health System has no federal loans or loan guarantees outstanding as of December 31, 2024. De Minimis Rate Used: N Rate Explanation: The auditee elected to not use the deminimis cost rate. The accompanying Schedule of Expenditures of Federal Awards (Schedule) includes the federal award activity of Intermountain Health Care, Inc. (the Health System) under programs of the federal government for the year ended December 31, 2024. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200 (2 CFR 200), Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Health System, it is not intended to and does not present the balance sheet, results of operations and changes in net assets, or cash flows of the Health System.
Title: 2. Summary of Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in 45 CFR 74, Appendix E or the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The Health System has no federal loans or loan guarantees outstanding as of December 31, 2024. De Minimis Rate Used: N Rate Explanation: The auditee elected to not use the deminimis cost rate. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in 45 CFR 74, Appendix E or the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The Health System has no federal loans or loan guarantees outstanding as of December 31, 2024.
Title: 3. Indirect Cost Rate Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in 45 CFR 74, Appendix E or the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The Health System has no federal loans or loan guarantees outstanding as of December 31, 2024. De Minimis Rate Used: N Rate Explanation: The auditee elected to not use the deminimis cost rate. The Health System has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.